Sentix: A prospective observational trial on sentinel lymph node biopsy in patients with early stage cervical cancer

Sentix: A prospective observational trial on sentinel lymph node biopsy in patients with early stage cervical cancer - Sentix

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48708

Enrollment

Registered

2017-09-18

Start date

2017-11-24

Completion date

Unknown

Last updated

2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Cervical cancer

Exclusion criteria

Exclusion criteria: Unable to understand protocol

Design outcomes

Primary

Measure	Time frame
Recurrence rate at the 24th month of follow-up	—

Secondary

Measure	Time frame
Prevalence of symptomatic pelvic lymphocele and lower extremity lymphedema, the two complications that are associated with lymph node staging.	—

Countries

Netherlands

Outcome results